<!DOCTYPE html>
<!-- saved from url=(0083)https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm -->
<html class="" data-reactroot=""><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script src="./262.癌症分期 - 搜狗科学百科_files/analytics.js.download" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app204.us.archive.org';v.server_ms=1544;archive_analytics.send_pageview({});});</script>
<script type="text/javascript" src="./262.癌症分期 - 搜狗科学百科_files/bundle-playback.js.download" charset="utf-8"></script>
<script type="text/javascript" src="./262.癌症分期 - 搜狗科学百科_files/wombat.js.download" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://baike.sogou.com/kexue/d10262.htm","20221028222951","https://web.archive.org/","web","/_static/",
	      "1666996191");
</script>
<link rel="stylesheet" type="text/css" href="./262.癌症分期 - 搜狗科学百科_files/banner-styles.css">
<link rel="stylesheet" type="text/css" href="./262.癌症分期 - 搜狗科学百科_files/iconochive.css">
<!-- End Wayback Rewrite JS Include -->
<meta name="save" content="history"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="baidu-site-verification" content="VWGb6TyYx8"><meta content="癌症分期 - 搜狗科学百科" name="keywords"><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"><meta http-equiv="x-dns-prefetch-control" content="on"><meta name="server" baike="235" ip="210" env="online"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://cache.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://hhy.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://pic.baike.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://ugc.qpic.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://xui.ptlogin2.qq.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://q1.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://q2.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://q3.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://q4.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://q.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://img01.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://img02.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://img03.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028222951/https://img04.sogoucdn.com/"><link rel="Shortcut Icon" href="https://web.archive.org/web/20221028222951im_/https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link rel="Bookmark" href="https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link href="./262.癌症分期 - 搜狗科学百科_files/base_b849887.css" rel="stylesheet"><link href="./262.癌症分期 - 搜狗科学百科_files/detail_378aed5.css" rel="stylesheet"><link href="./262.癌症分期 - 搜狗科学百科_files/inviteAudit_7894507.css" rel="stylesheet"><link rel="stylesheet" href="./262.癌症分期 - 搜狗科学百科_files/highlight.min.css"><title>癌症分期 - 搜狗科学百科</title><style>.onekey-close {
	position: absolute;
	top: 16px;
	right: 16px;
	width: 24px;
	height: 24px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	text-indent: -999em;
	background-size: 84px;
	background-position: -63px 0;
}

.onekey-login {
	position: absolute;
	top: 16.4%;
	left: 0;
	right: 0;
	width: 100%;
}

/* .onekey-login-img {
    width: 75px;
    height: 75px;
    background: url("https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/images/sprite_wap_baike.png") no-repeat;
    background-size: 100px 91px;
    background-position: 0 0;
    background-repeat: no-repeat;
    margin: 0 auto;
} */

.onekey-login-title {
	text-align: center;
	padding-bottom: 3px;
	font-size: 21px;
	font-weight: bold;
	line-height: 30px;
	color: #000;
}

.onekey-login-txt {
	text-align: center;
	font-family: PingFangSC;
	font-size: 14px;
	line-height: 20px;
	color: #8f8f8f;
}

.onekey-login-qq,
.onekey-login-wx,
.onekey-login-phone {
	display: block;
	width: 245px;
	height: 54px;
	border-radius: 45px;
	text-align: center;

	margin: 0 auto;
	font-size: 17px;
	line-height: 24px;
	color: #000;
	/* padding: 16px 77px; */
	border-radius: 12px;
	border: solid 1px #e0e0e0;
}
.onekey-qq-content,
.onekey-vx-content,
.onekey-phone-content {
	display: inline-block;
	margin-top: 16px;
}
.onekey-qq-content {
	padding: 0 5px;
}

.onekey-login-qq {
	margin-top: 48px;
	margin-bottom: 24px;
}

.onekey-login-qq:before {
	display: inline-block;
	content: "";
	width: 20px;
	height: 20px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 80px;
	background-position: -20px 0;
	vertical-align: top;
	margin: 17px 8px 0 0;
}

.onekey-login-wx {
	margin-bottom: 24px;
}

.onekey-login-wx:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: 0 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-login-phone {
}

.onekey-login-phone:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: -42px 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-fixed {
	z-index: 100;
	position: fixed;
	top: 0;
	bottom: 0;
	left: 0;
	right: 0;
	background: #fff;
	width: 100%;
	height: 100%;
}

.onekey-fixed.forbid {
	z-index: 100;
	position: fixed;
	top: auto;
	bottom: 68px;
	left: 9%;
	right: 0;
	background: rgba(0, 0, 0, 0.7);
	width: 82%;
	height: 43px;
	border-radius: 25px;
	color: #ffffff;
}
.onekey-login-title.forbid {
	text-align: center;
	padding-bottom: 3px;
	font-size: 14px;
	font-weight: normal;
	line-height: 30px;
	color: white;
}
</style><style>#login_mask {
  background: #000;
  opacity: 0.5;
  filter: alpha(opacity=50);
  position: fixed;
  /*fixed好像在哪个IE上有BUG，先用用*/
  left: 0;
  top: 0;
  z-index: 999;
  height: 100%;
}

#login_iframe_container {
  position: fixed;
  width: 550px;
  height: 360px;
  z-index: 1020;
  background-color: #ffffff;
}

@media screen and (max-width: 828px) {
  #login_iframe_container {
    top: 50% !important;
    left: 50% !important;
    transform: translate(-50%, -50%);
  }
}

#login_iframe_container.new-login {
  width: 550px;
  height: 360px;
  background-image: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/background_2a4a8a6.png);
}

#login_iframe_container.new-login.no-bg {
  background: #fff;
}

#login_iframe_container.new-login .login-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 30px;
  letter-spacing: 0.19px;
  color: #ffffff;
  margin-top: 62px;
}
#login_iframe_container.new-login .forbid-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 24px;
  letter-spacing: 0.19px;
  color: #333333;
  margin-top: 150px;
}

#login_iframe_container.new-login.no-bg .login-title {
  color: #333333;
}

#login_iframe_container.new-login .login-subtitle {
  width: 100%;
  height: 18px;
  line-height: 18px;
  font-size: 13px;
  letter-spacing: 0.08px;
  color: #ffffff;
  text-align: center;
  margin-top: 9px;
  margin-bottom: 43px;
}

#login_iframe_container.new-login.no-bg .login-subtitle {
  color: #999999;
}

#login_iframe_container.new-login .login-subtitle::before {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: -5px;
}

#login_iframe_container.new-login .login-subtitle::after {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: 5px;
}

#login_iframe_container.new-login.no-bg .login-subtitle::before {
  background-color: #999999;
}

#login_iframe_container.new-login.no-bg .login-subtitle::after {
  background-color: #999999;
}

#login_iframe_container.new-login .close-btn {
  position: absolute;
  top: 20px;
  right: 20px;
  width: 12px;
  height: 12px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -59px -10px;
  background-size: 81px 91px;
  cursor: pointer;
}

#login_iframe_container.new-login .login-btn {
  width: 220px;
  height: 47px;
  border-radius: 24px;
  border: solid 1px #dddddd;
  background-color: #ffffff;
  margin: 0 auto;
  margin-top: 28px;
  position: relative;
  display: block;
}

#login_iframe_container.new-login .login-btn .login-icon {
  position: absolute;
}

#login_iframe_container.new-login .login-btn .login-text {
  width: 61px;
  height: 47px;
  line-height: 47px;
  vertical-align: middle;
  font-size: 15px;
  letter-spacing: 0.1px;
  color: #666666;
  position: absolute;
  right: 62px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-icon {
  width: 22px;
  height: 27px;
  top: 10px;
  left: 67px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -54px;
  background-size: 81px 91px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-text {
  right: 59px;
}

#login_iframe_container.new-login .login-btn.wechat-btn .login-icon {
  width: 29px;
  height: 24px;
  top: 12px;
  left: 62px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -10px;
  background-size: 81px 91px;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style></head><body class=""><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display: block; direction: ltr;">
</div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm</div>
<script type="text/javascript">//<![CDATA[
__wm.bt(675,27,25,2,"web","https://baike.sogou.com/kexue/d10262.htm","20221028222951",1996,"/_static/",["/_static/css/banner-styles.css?v=S1zqJCYt","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
//]]></script>
<!-- END WAYBACK TOOLBAR INSERT --><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('01cfabbcc1014e2383d3ee1cfd9299b1') window._gtag.traceId = '01cfabbcc1014e2383d3ee1cfd9299b1';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="https://web.archive.org/web/20221028222951/https://www.sogou.com/web?query=">网页</a></li><li><a href="https://web.archive.org/web/20221028222951/https://weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="https://web.archive.org/web/20221028222951/https://zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="https://web.archive.org/web/20221028222951/https://pic.sogou.com/pics?query=">图片</a></li><li><a href="https://web.archive.org/web/20221028222951/https://v.sogou.com/v?query=">视频</a></li><li><a href="https://web.archive.org/web/20221028222951/https://mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="https://web.archive.org/web/20221028222951/https://hanyu.sogou.com/">汉语</a></li><li><a href="https://web.archive.org/web/20221028222951/https://wenwen.sogou.com/">问问</a></li><li><a href="https://web.archive.org/web/20221028222951/https://www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header"><div class="header-wrap"><a class="header-logo" href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"><form><input id="searchInput" class="query" type="text" placeholder="搜科学领域专业百科词条" name="query" autocomplete="off" value=""><a href="javascript:;" class="query-search"></a></form></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>癌症分期</h1><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="14995081413001731"><div><p>癌症分期是根据肿瘤大小及其播散程度来评估癌症进展程度的方法。目前的方法是将癌症分为I到IV四种级别， I代表孤立性癌， IV代表肿瘤转移灶大小已达到所能评估测量的最小值。分期通常会考虑肿瘤的大小、是否浸润邻近器官、扩散到多少区域（周围）淋巴结（如有）以及它是否出现在躯体的远隔部位（转移）。 </p></div></div><div id="catalog"><h2 class="title2">目录<a href="javascript:" class="detail-edit">编辑</a></h2><div class="catalog_wrap" style=""><ul class="catalog_list col2"><li><span class="order">1</span><a href="javascript:" data-level="1" data-id="14995081413001732">TNM分期系统</a></li><li><span class="order">2</span><a href="javascript:" data-level="1" data-id="14995081413001733">影响因素</a></li><li class="secondary_catalog"><span>2.1 </span><a href="javascript:" data-id="14995081413001733">病理方面</a></li><li class="secondary_catalog"><span>2.2 </span><a href="javascript:" data-id="14995081413001733">最新研究</a></li><li><span class="order">3</span><a href="javascript:" data-level="1" data-id="14995081413001734">分期系统</a></li><li class="secondary_catalog"><span>3.1 </span><a href="javascript:" data-id="14995081413001734">血液系统肿瘤</a></li></ul><ul class="catalog_list col2"><li class="secondary_catalog"><span>3.2 </span><a href="javascript:" data-id="14995081413001734">实体瘤</a></li><li><span class="order">4</span><a href="javascript:" data-level="1" data-id="14995081429778944">总体分期分组</a></li><li><span class="order">5</span><a href="javascript:" data-level="1" data-id="14995081429778945">分期偏移</a></li><li><span class="order">6</span><a href="javascript:" data-level="1" data-id="references">参考文献</a></li></ul></div></div><div id="paragraphs"><div><div id="par_14995081413001732"><h2 class="title">1 TNM分期系统<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>癌症分期可分为临床分期和病理分期。在TNM（肿瘤、淋巴结、转移）系统中，临床分期和病理分期之前分别用小写的“c”或“p”进行区分（例如cT3N1M0或pT2N0）。这种分期系统用于除脑肿瘤和血液系统恶性肿瘤之外的大多数癌症。 </p> 
<ul>
 <li>临床分期的判断主要基于肿瘤切除手术前获得的所有可用信息，包括体格检查、血液测试、放射检查、病理活检和内窥镜检查等获得的关于肿瘤的信息。</li> 
 <li>病理分期则在以上信息的基础上增加了肿瘤切除后病理学专家通过显微镜检查肿瘤组织获得的信息。</li>
</ul> 
<p>因为所使用的标准不同，临床分期和病理分期往往不一致。通常认为病理分期更为准确，因为它可以直接检查肿瘤整体。相比之下临床分期有一定的限制性，因为临床分期所用的相关信息是通过对仍在体内的肿瘤进行间接观察而获得的。但临床分期和病理分期往往相辅相成。并非每个肿瘤患者都是通过手术治疗的，所以并非所有肿瘤都能进行病理分期。此外，有时手术之前会进行其它治疗，如化疗和放疗，由于治疗后肿瘤的缩小，病理分期可能会低于肿瘤的实际分期。 </p></div></div><div id="par_14995081413001733"><h2 class="title">2 影响因素<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>正确的分期至关重要，因为分期不同治疗方式也会不同（特别是对于需要术前治疗和/或辅助治疗，以及需要对手术范围进行预估的患者）。因此，不准确的分期将会导致治疗不当。 </p>
<p>对于一些常见的癌症，分期方法是有明确规定的。例如，对于乳腺癌和前列腺癌，医生通常可以辨别并确定某些患者的癌症是早期的，并且转移风险较低。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_1" class="kx_ref">[1]</a></sup> 对于这些患者，医学专业组织不推荐PET CT、CT、骨扫描检查，因为研究表明，患者接受这些检查过程中的风险超过了检查可能的带来的好处。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_1" class="kx_ref">[1]</a></sup> 过度检查会导致一些问题，包括患者接受侵入性检查、过度利用医疗服务、受到不必要的辐射以及出现误诊。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_1" class="kx_ref">[1]</a></sup> </p> 
<h3>2.1 <span>病理方面</span></h3> 
<p>病理学家检查组织切片，决定癌症的病理分期时，有两个特殊因素可能影响分期结果：视觉的主观性和标本取样的随机性。“视觉主观性”是指对在健康细胞中混合的单个癌细胞的区分于鉴别的差异。漏看一个癌细胞便可导致分期出错，进而导致严重及预料之外的癌症扩散。“随机取样”指的是所检查的淋巴结是从患者身上随机挑选的，如果淋巴结中存在的癌细胞碰巧不在所随机取样、切片所观察的组织切片中，可能会导致分期有误和治疗不当。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_2" class="kx_ref">[2]</a></sup> </p> 
<h3>2.2 <span>最新研究</span></h3> 
<p>最新的高敏感度分期方法正在开发中。例如，GCC（鸟苷酸环化酶c）的mRNA仅存在于肠上皮的肠腔面的细胞中，且可以用具有高度敏感性和准确性的分子检测（RT-PCR）来鉴定。GCC若出现在在身体任何其他组织中，则说明有结肠直肠上皮化生。由于其高灵敏度，RT-PCR检测GCC的方法大大降低了低估疾病分期的发生率。研究人员希望这种精确的分期能为患者带来更合适的治疗和更好的预后。此外，研究人员还希望该技术可以应用于其他组织特异性蛋白的检测中。 </p></div></div><div id="par_14995081413001734"><h2 class="title">3 分期系统<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>不同类型的肿瘤分期方式不同（例如乳腺癌和肺癌），但有一些癌症没有分期系统。尽管某些类型的癌症存在不同的分期系统，但医生普遍接受的分期系统是UICC系统，该系统对一些特定肿瘤分期的规定与AJCC相同。 </p>
<p>不同疾病或同一疾病不同体征的分期系统可能不同。 </p> 
<h3>3.1 <span>血液系统肿瘤</span></h3> 
<ul>
 <li>淋巴瘤：采用Ann Arbor分期</li> 
 <li>霍奇金病：分期遵循分为I至IV期的量表，根据患者是否无症状或有发烧等症状，可进一步用A或B表示。一般称为“科茨沃尔德系统”或“改良Ann Arbor分级系统”。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_3" class="kx_ref">[3]</a></sup></li>
</ul> 
<h3>3.2 <span>实体瘤</span></h3> 
<p>对于实体肿瘤，TNM是目前最常用的系统，但根据肿瘤类型不同有相应的调整。 </p> 
<ul>
 <li>乳腺癌：乳腺癌分期主要基于TNM系统，<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_4" class="kx_ref">[4]</a></sup> 但是I-IV期的分期方法有时也有使用。</li> 
 <li>宫颈癌和卵巢癌： 将“FIGO”分期系统引入了TNM系统。对于癌变不典型增生，使用CIN（宫颈上皮内瘤样病变）分级系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_5" class="kx_ref">[5]</a></sup></li> 
 <li>结肠癌：最初由A， B， C， D四期组成 （杜克分期系统）。但近年来，结肠癌分期既可依据杜克分期系统也可依据TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_6" class="kx_ref">[6]</a></sup></li> 
 <li>肾癌：使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_7" class="kx_ref">[7]</a></sup></li> 
 <li>喉癌：使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_8" class="kx_ref">[8]</a></sup></li> 
 <li>肝癌：使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_9" class="kx_ref">[9]</a></sup></li> 
 <li>肺癌：使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_10" class="kx_ref">[10]</a></sup></li> 
 <li>黑色素瘤：使用TNM分期系统。但“Clark分级”和“Breslow深度”也同样重要，它们指的是显微镜观察下的肿瘤浸润深度。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_11" class="kx_ref">[11]</a></sup></li> 
 <li>前列腺癌：国际普遍使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_12" class="kx_ref">[12]</a></sup></li> 
 <li>睾丸癌：使用TNM分期系统和血清标记物测定（TNMS）。</li> 
 <li>非黑色素瘤皮肤癌：使用TNM分期系统。</li> 
 <li>膀胱癌：使用TNM分期系统。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_13" class="kx_ref">[13]</a></sup></li>
</ul></div></div><div id="par_14995081429778944"><h2 class="title">4 总体分期分组<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img03.sogoucdn.com/app/a/200698/sogou_science_11088" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true"></a>
            <div class="text_img_title" style="text-align: center;"></div>   
        </div> 
<p>总体分期分组也称为罗马数字分期。该系统使用数字I 、 II 、 III &nbsp;、IV（以及0）来描述癌症的进展。 </p> 
<ul>
 <li>0期：原位癌，即在正常部位生长的异常细胞。</li> 
 <li>I期：癌症局限于身体的某一部位。如果足够小，I期癌症可以通过手术切除。</li> 
 <li>II期：癌症局部晚期。II期癌症可以通过化疗、放疗或手术进行治疗。</li> 
 <li>III期：同样为癌症局部晚期。癌症被指定为II期还是III期取决于癌症的具体类型；例如，在霍奇金病中，II期发生转移的淋巴结位于膈肌一侧，III期膈肌两侧的淋巴结均发生了转移。因此，II期和III期的具体标准因肿瘤类别而异。 III期可以通过化疗、放疗或手术进行治疗。</li> 
 <li>IV期：癌症通常已转移到其他器官或播散至全身。 IV期癌症可以通过化疗、放疗或手术进行治疗。但IV期癌症患者的死亡率在治疗后依旧很高，例如癌症很可能会继续进展。</li> 
 <li>V期：第五阶段仅用于肾母细胞瘤患者，指诊断时肿瘤已累及双肾。大约5%的肾母细胞瘤患者确诊时为V期。</li>
</ul> 
<p>在TNM系统中，癌症也可能被定义为复发，这意味着肿瘤消退后或在所有可见肿瘤被消除后，肿瘤再次出现。复发既可以是局部的，即复发肿瘤在原始肿瘤生长的部位再次出现；也可以是远处复发，即肿瘤出现在其他的身体部位。 </p></div></div><div id="par_14995081429778945"><h2 class="title">5 分期偏移<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>分期偏移是特定癌症人群中癌症分期的分布变化，其发生是由于分期系统本身的变化或由于检测技术变得更为敏感（例如使用磁共振成像扫描），导致癌症转移更易被发现 。分期偏移会导致有趣的统计现象（如威尔·罗杰斯现象）。泌尿系统癌症是第四位最常见的癌症，分期系统在这一领域至关重要。<sup><a href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/d10262.htm#quote_14" class="kx_ref">[14]</a></sup> </p></div></div></div></div><div id="references"><h2 class="title" id="par_references">参考文献</h2><ul class="references"><li id="quote_1"><span class="references-num">[1]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">American Society of Clinical Oncology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American Society of Clinical Oncology, archived from the original (PDF) on July 31, 2012, retrieved August 14, 2012, citing Carlson, R. W.; Allred, D. C.; Anderson, B. O.; Burstein, H. J.; Carter, W. B.; Edge, S. B.; Erban, J. K.; Farrar, W. B.; Goldstein, L. J.; Gradishar, W. J.; Hayes, D. F.; Hudis, C. A.; Jahanzeb, M.; Kiel, K.; Ljung, B. M.; Marcom, P. K.; Mayer, I. A.; McCormick, B.; Nabell, L. M.; Pierce, L. J.; Reed, E. C.; Smith, M. L.; Somlo, G.; Theriault, R. L.; Topham, N. S.; Ward, J. H.; Winer, E. P.; Wolff, A. C.; NCCN Breast Cancer Clinical Practice Guidelines Panel (2009). "Breast cancer. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network : JNCCN. 7 (2): 122–192. PMID 19200416. Thompson, I.; Thrasher, J. B.; Aus, G.; Burnett, A. L.; Canby-Hagino, E. D.; Cookson, M. S.; d'Amico, A. V.; Dmochowski, R. R.; Eton, D. T.; Forman, J. D.; Goldenberg, S. L.; Hernandez, J.; Higano, C. S.; Kraus, S. R.; Moul, J. W.; Tangen, C. M.; AUA Prostate Cancer Clinical Guideline Update Panel (2007). "Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update". The Journal of Urology. 177 (6): 2106–2131. doi:10.1016/j.juro.2007.03.003. PMID 17509297..</span></p></li><li id="quote_2"><span class="references-num">[2]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Early trauma may be risk factor for anxiety and depression in adults with head/neck cancer". Eureka Alert. Eureka Alert. Retrieved 6 August 2018..</span></p></li><li id="quote_3"><span class="references-num">[3]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Hodgkin's Disease - Staging". oncologychannel. Retrieved 2010-10-14..</span></p></li><li id="quote_4"><span class="references-num">[4]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Breast Cancer Treatment - National Cancer Institute". Cancer.gov. 2010-08-13. Retrieved 2010-10-14..</span></p></li><li id="quote_5"><span class="references-num">[5]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Eric Lucas (2006-01-31). "FIGO staging of cervical carcinomas". Screening.iarc.fr. Retrieved 2010-10-14..</span></p></li><li id="quote_6"><span class="references-num">[6]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Colon Cancer - Staging". oncologychannel. Retrieved 2010-10-14..</span></p></li><li id="quote_7"><span class="references-num">[7]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Stages of kidney cancer". Cancerhelp.org.uk. 2010-06-30. Archived from the original on 2009-01-22. Retrieved 2010-10-14..</span></p></li><li id="quote_8"><span class="references-num">[8]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"The stages of cancer of the larynx". Cancerhelp.org.uk. 2010-07-28. Archived from the original on 2008-12-16. Retrieved 2010-10-14..</span></p></li><li id="quote_9"><span class="references-num">[9]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"How is liver cancer staged?". Retrieved 2013-06-02..</span></p></li><li id="quote_10"><span class="references-num">[10]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Imaging in Lung Cancer Staging 于 eMedicine.</span></p></li><li id="quote_11"><span class="references-num">[11]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"malignant melanoma: staging". Chorus.rad.mcw.edu. Archived from the original on 2010-07-18. Retrieved 2010-10-14..</span></p></li><li id="quote_12"><span class="references-num">[12]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"NCCN Guidelines for Patients". National Comprehensive Cancer Network. Retrieved 2015-11-01..</span></p></li><li id="quote_13"><span class="references-num">[13]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Bladder Cancer Stages". Cancer.org. American Cancer Society. Retrieved 29 December 2017..</span></p></li><li id="quote_14"><span class="references-num">[14]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Does the Gross Prosector Impact pT3 Subclassification or Lymph Node Counts in Bladder Cancer? – Beyond the Abstract". Uro Today. Uro today. Retrieved 6 August 2018..</span></p></li></ul></div><div class="read-num">阅读 <!-- -->355</div></div><div class="right-side" id="rightSide"><div class="side" id="lemma-side"><div class="side-title">版本记录</div><ul class="side-lst"><li><p class="side-lst-txt">暂无</p></li></ul><div class="user-card userCard"></div></div><div class="side"><div class="side-event"></div></div></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://web.archive.org/web/20221028222951/https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="https://web.archive.org/web/20221028222951/http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="https://web.archive.org/web/20221028222951/http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://web.archive.org/web/20221028222951/https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"10262","versionId":"14995265157071360","title":"癌症分期","subtitle":"","abstracts":{"paragraphId":"14995081413001731","title":"简介","versionId":"14995265157071361","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>癌症分期是根据肿瘤大小及其播散程度来评估癌症进展程度的方法。目前的方法是将癌症分为I到IV四种级别， I代表孤立性癌， IV代表肿瘤转移灶大小已达到所能评估测量的最小值。分期通常会考虑肿瘤的大小、是否浸润邻近器官、扩散到多少区域（周围）淋巴结（如有）以及它是否出现在躯体的远隔部位（转移）。 </p>","pics":null,"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"0","title":null,"versionId":"0","lemmaId":0,"createType":0,"creator":null,"createTime":0,"versionEditor":null,"editTime":0,"comment":null,"dependVersionId":0,"contentType":0,"content":null,"pics":null,"card":null,"references":null,"versionCount":0},"categories":[{"id":13,"name":"药学","parents":[]}],"creator":{"uid":76052688,"name":"王一鑫","pic":"https://web.archive.org/web/20221028222951/https://cache.soso.com/qlogo/g?b=oidb&k=J98zKlez9iaWgwHsRmHmYicA&s=100&t=1555573700","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":157,"partnerIdCreateTime":1595844884,"partnerIdPoped":false},"createTime":1568622504,"editor":{"uid":76052688,"name":"王一鑫","pic":"https://web.archive.org/web/20221028222951/https://cache.soso.com/qlogo/g?b=oidb&k=J98zKlez9iaWgwHsRmHmYicA&s=100&t=1555573700","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":157,"partnerIdCreateTime":1595844884,"partnerIdPoped":false},"editTime":1576233873,"state":1,"versionCount":2,"upNum":1,"downNum":0,"pics":[{"originalUrl":"https://web.archive.org/web/20221028222951/https://img03.sogoucdn.com/app/a/200698/sogou_science_11088?w=500&h=247&titlename=","url":"https://web.archive.org/web/20221028222951/https://img03.sogoucdn.com/app/a/200698/sogou_science_11088","rw":500,"rh":247,"title":"","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"TNM分期系统","paragraphId":"14995081413001732","subCatalogs":null},{"level":1,"title":"影响因素","paragraphId":"14995081413001733","subCatalogs":[{"level":2,"title":"病理方面","paragraphId":"14995081413001733","subCatalogs":null},{"level":2,"title":"最新研究","paragraphId":"14995081413001733","subCatalogs":null}]},{"level":1,"title":"分期系统","paragraphId":"14995081413001734","subCatalogs":[{"level":2,"title":"血液系统肿瘤","paragraphId":"14995081413001734","subCatalogs":null},{"level":2,"title":"实体瘤","paragraphId":"14995081413001734","subCatalogs":null}]},{"level":1,"title":"总体分期分组","paragraphId":"14995081429778944","subCatalogs":null},{"level":1,"title":"分期偏移","paragraphId":"14995081429778945","subCatalogs":null},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"14995081413001732","title":"TNM分期系统","versionId":"14995265157071362","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>癌症分期可分为临床分期和病理分期。在TNM（肿瘤、淋巴结、转移）系统中，临床分期和病理分期之前分别用小写的“c”或“p”进行区分（例如cT3N1M0或pT2N0）。这种分期系统用于除脑肿瘤和血液系统恶性肿瘤之外的大多数癌症。 </p> \n<ul>\n <li>临床分期的判断主要基于肿瘤切除手术前获得的所有可用信息，包括体格检查、血液测试、放射检查、病理活检和内窥镜检查等获得的关于肿瘤的信息。</li> \n <li>病理分期则在以上信息的基础上增加了肿瘤切除后病理学专家通过显微镜检查肿瘤组织获得的信息。</li>\n</ul> \n<p>因为所使用的标准不同，临床分期和病理分期往往不一致。通常认为病理分期更为准确，因为它可以直接检查肿瘤整体。相比之下临床分期有一定的限制性，因为临床分期所用的相关信息是通过对仍在体内的肿瘤进行间接观察而获得的。但临床分期和病理分期往往相辅相成。并非每个肿瘤患者都是通过手术治疗的，所以并非所有肿瘤都能进行病理分期。此外，有时手术之前会进行其它治疗，如化疗和放疗，由于治疗后肿瘤的缩小，病理分期可能会低于肿瘤的实际分期。 </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14995081413001733","title":"影响因素","versionId":"14995265157071363","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>正确的分期至关重要，因为分期不同治疗方式也会不同（特别是对于需要术前治疗和/或辅助治疗，以及需要对手术范围进行预估的患者）。因此，不准确的分期将会导致治疗不当。 </p>\n<p>对于一些常见的癌症，分期方法是有明确规定的。例如，对于乳腺癌和前列腺癌，医生通常可以辨别并确定某些患者的癌症是早期的，并且转移风险较低。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 对于这些患者，医学专业组织不推荐PET CT、CT、骨扫描检查，因为研究表明，患者接受这些检查过程中的风险超过了检查可能的带来的好处。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 过度检查会导致一些问题，包括患者接受侵入性检查、过度利用医疗服务、受到不必要的辐射以及出现误诊。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> </p> \n<h3>病理方面</h3> \n<p>病理学家检查组织切片，决定癌症的病理分期时，有两个特殊因素可能影响分期结果：视觉的主观性和标本取样的随机性。“视觉主观性”是指对在健康细胞中混合的单个癌细胞的区分于鉴别的差异。漏看一个癌细胞便可导致分期出错，进而导致严重及预料之外的癌症扩散。“随机取样”指的是所检查的淋巴结是从患者身上随机挑选的，如果淋巴结中存在的癌细胞碰巧不在所随机取样、切片所观察的组织切片中，可能会导致分期有误和治疗不当。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup> </p> \n<h3>最新研究</h3> \n<p>最新的高敏感度分期方法正在开发中。例如，GCC（鸟苷酸环化酶c）的mRNA仅存在于肠上皮的肠腔面的细胞中，且可以用具有高度敏感性和准确性的分子检测（RT-PCR）来鉴定。GCC若出现在在身体任何其他组织中，则说明有结肠直肠上皮化生。由于其高灵敏度，RT-PCR检测GCC的方法大大降低了低估疾病分期的发生率。研究人员希望这种精确的分期能为患者带来更合适的治疗和更好的预后。此外，研究人员还希望该技术可以应用于其他组织特异性蛋白的检测中。 </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14995081413001734","title":"分期系统","versionId":"14995265157071364","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>不同类型的肿瘤分期方式不同（例如乳腺癌和肺癌），但有一些癌症没有分期系统。尽管某些类型的癌症存在不同的分期系统，但医生普遍接受的分期系统是UICC系统，该系统对一些特定肿瘤分期的规定与AJCC相同。 </p>\n<p>不同疾病或同一疾病不同体征的分期系统可能不同。 </p> \n<h3>血液系统肿瘤</h3> \n<ul>\n <li>淋巴瘤：采用Ann Arbor分期</li> \n <li>霍奇金病：分期遵循分为I至IV期的量表，根据患者是否无症状或有发烧等症状，可进一步用A或B表示。一般称为“科茨沃尔德系统”或“改良Ann Arbor分级系统”。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup></li>\n</ul> \n<h3>实体瘤</h3> \n<p>对于实体肿瘤，TNM是目前最常用的系统，但根据肿瘤类型不同有相应的调整。 </p> \n<ul>\n <li>乳腺癌：乳腺癌分期主要基于TNM系统，<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup> 但是I-IV期的分期方法有时也有使用。</li> \n <li>宫颈癌和卵巢癌： 将“FIGO”分期系统引入了TNM系统。对于癌变不典型增生，使用CIN（宫颈上皮内瘤样病变）分级系统。<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup></li> \n <li>结肠癌：最初由A， B， C， D四期组成 （杜克分期系统）。但近年来，结肠癌分期既可依据杜克分期系统也可依据TNM分期系统。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup></li> \n <li>肾癌：使用TNM分期系统。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup></li> \n <li>喉癌：使用TNM分期系统。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup></li> \n <li>肝癌：使用TNM分期系统。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup></li> \n <li>肺癌：使用TNM分期系统。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup></li> \n <li>黑色素瘤：使用TNM分期系统。但“Clark分级”和“Breslow深度”也同样重要，它们指的是显微镜观察下的肿瘤浸润深度。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup></li> \n <li>前列腺癌：国际普遍使用TNM分期系统。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup></li> \n <li>睾丸癌：使用TNM分期系统和血清标记物测定（TNMS）。</li> \n <li>非黑色素瘤皮肤癌：使用TNM分期系统。</li> \n <li>膀胱癌：使用TNM分期系统。<sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup></li>\n</ul>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14995081429778944","title":"总体分期分组","versionId":"14995265157071365","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":1,"content":"<img alt=\"Cancer Stages\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"247\" img_width=\"500\" titlename=\"\" data-src=\"https://img03.sogoucdn.com/app/a/200698/sogou_science_11088\"> \n<p>总体分期分组也称为罗马数字分期。该系统使用数字I 、 II 、 III &nbsp;、IV（以及0）来描述癌症的进展。 </p> \n<ul>\n <li>0期：原位癌，即在正常部位生长的异常细胞。</li> \n <li>I期：癌症局限于身体的某一部位。如果足够小，I期癌症可以通过手术切除。</li> \n <li>II期：癌症局部晚期。II期癌症可以通过化疗、放疗或手术进行治疗。</li> \n <li>III期：同样为癌症局部晚期。癌症被指定为II期还是III期取决于癌症的具体类型；例如，在霍奇金病中，II期发生转移的淋巴结位于膈肌一侧，III期膈肌两侧的淋巴结均发生了转移。因此，II期和III期的具体标准因肿瘤类别而异。 III期可以通过化疗、放疗或手术进行治疗。</li> \n <li>IV期：癌症通常已转移到其他器官或播散至全身。 IV期癌症可以通过化疗、放疗或手术进行治疗。但IV期癌症患者的死亡率在治疗后依旧很高，例如癌症很可能会继续进展。</li> \n <li>V期：第五阶段仅用于肾母细胞瘤患者，指诊断时肿瘤已累及双肾。大约5%的肾母细胞瘤患者确诊时为V期。</li>\n</ul> \n<p>在TNM系统中，癌症也可能被定义为复发，这意味着肿瘤消退后或在所有可见肿瘤被消除后，肿瘤再次出现。复发既可以是局部的，即复发肿瘤在原始肿瘤生长的部位再次出现；也可以是远处复发，即肿瘤出现在其他的身体部位。 </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028222951/https://img03.sogoucdn.com/app/a/200698/sogou_science_11088?w=500&h=247&titlename=","url":"https://web.archive.org/web/20221028222951/https://img03.sogoucdn.com/app/a/200698/sogou_science_11088","rw":500,"rh":247,"title":"","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14995081429778945","title":"分期偏移","versionId":"14995265157071366","lemmaId":10262,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":76052688,"name":"王一鑫","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1576233873,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>分期偏移是特定癌症人群中癌症分期的分布变化，其发生是由于分期系统本身的变化或由于检测技术变得更为敏感（例如使用磁共振成像扫描），导致癌症转移更易被发现 。分期偏移会导致有趣的统计现象（如威尔·罗杰斯现象）。泌尿系统癌症是第四位最常见的癌症，分期系统在这一领域至关重要。<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"book","title":"American Society of Clinical Oncology, \"Five Things Physicians and Patients Should Question\" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American Society of Clinical Oncology, archived from the original (PDF) on July 31, 2012, retrieved August 14, 2012, citing Carlson, R. W.; Allred, D. C.; Anderson, B. O.; Burstein, H. J.; Carter, W. B.; Edge, S. B.; Erban, J. K.; Farrar, W. B.; Goldstein, L. J.; Gradishar, W. J.; Hayes, D. F.; Hudis, C. A.; Jahanzeb, M.; Kiel, K.; Ljung, B. M.; Marcom, P. K.; Mayer, I. A.; McCormick, B.; Nabell, L. M.; Pierce, L. J.; Reed, E. C.; Smith, M. L.; Somlo, G.; Theriault, R. L.; Topham, N. S.; Ward, J. H.; Winer, E. P.; Wolff, A. C.; NCCN Breast Cancer Clinical Practice Guidelines Panel (2009). \"Breast cancer. Clinical practice guidelines in oncology\". Journal of the National Comprehensive Cancer Network : JNCCN. 7 (2): 122–192. PMID 19200416. Thompson, I.; Thrasher, J. B.; Aus, G.; Burnett, A. L.; Canby-Hagino, E. D.; Cookson, M. S.; d'Amico, A. V.; Dmochowski, R. R.; Eton, D. T.; Forman, J. D.; Goldenberg, S. L.; Hernandez, J.; Higano, C. S.; Kraus, S. R.; Moul, J. W.; Tangen, C. M.; AUA Prostate Cancer Clinical Guideline Update Panel (2007). \"Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update\". The Journal of Urology. 177 (6): 2106–2131. doi:10.1016/j.juro.2007.03.003. PMID 17509297.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"book","title":"\"Early trauma may be risk factor for anxiety and depression in adults with head/neck cancer\". Eureka Alert. Eureka Alert. Retrieved 6 August 2018.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"book","title":"\"Hodgkin's Disease - Staging\". oncologychannel. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"book","title":"\"Breast Cancer Treatment - National Cancer Institute\". Cancer.gov. 2010-08-13. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"book","title":"Eric Lucas (2006-01-31). \"FIGO staging of cervical carcinomas\". Screening.iarc.fr. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"book","title":"\"Colon Cancer - Staging\". oncologychannel. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"book","title":"\"Stages of kidney cancer\". Cancerhelp.org.uk. 2010-06-30. Archived from the original on 2009-01-22. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"book","title":"\"The stages of cancer of the larynx\". Cancerhelp.org.uk. 2010-07-28. Archived from the original on 2008-12-16. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"book","title":"\"How is liver cancer staged?\". Retrieved 2013-06-02.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"book","title":"Imaging in Lung Cancer Staging 于 eMedicine","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"book","title":"\"malignant melanoma: staging\". Chorus.rad.mcw.edu. Archived from the original on 2010-07-18. Retrieved 2010-10-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"book","title":"\"NCCN Guidelines for Patients\". National Comprehensive Cancer Network. Retrieved 2015-11-01.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"book","title":"\"Bladder Cancer Stages\". Cancer.org. American Cancer Society. Retrieved 29 December 2017.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":14,"type":"book","title":"\"Does the Gross Prosector Impact pT3 Subclassification or Lymph Node Counts in Bladder Cancer? – Beyond the Abstract\". Uro Today. Uro today. Retrieved 6 August 2018.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":355,"auditType":0,"synonyms":null,"showEditTime":"2019.12.13 18:44","auditors":[{"uid":0,"name":"Ki.κe","pic":"https://web.archive.org/web/20221028222951/https://wx.qlogo.cn/mmopen/vi_32/y67kfr32Doib4wg71Jiau7jVWvharic3nRKgdRRQSl6koeQJCo0GQs2Krw0vwdFRsOWnHIQOwAZsSg5lIkIrFCOcQ/132","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false}],"hasZhishiNav":false,"auditInfos":{},"isHistory":false};</script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/aegis.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/main_2020092401.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/jquery-1.11.1.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/main_2022062701.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/main_66bbe21.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./262.癌症分期 - 搜狗科学百科_files/main_edf0f08.js.download"></script>
</body></html>